Kinetic Concepts Inc.'s future will be tested in a six-week federal trial that begins today against two companies KCI claims infringed on its patents and trademarks. San Antonio-based KCI derives about 75 percent of its $1.2 billion in revenue from a wound-care device known as VAC, or vacuum assisted closure. It sued Bluesky Medical Inc. in 2003 for marketing a similar suction product called Versatile 1 and associated wound care dressings. San Antonio Express News (http://www.mysanantonio.com/business/stories/MYSA053106.1E.BIZkci.patent.170fc6c4.html)
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
Devicemakers Pay $9.5 Million for Selling Uncleared Products
The FDA hit Instrumed with a warning letter in 2014.
Federal Circuit Won’t Rehear Purdue Pharma’s OxyContin Patent Claims
The U.S. Court of Appeals for the Federal Circuit turned down Purdue’s appeal and upheld the PTAB ruling.
